Early diagnosis of airway inflammation in smokers: Still a challenge;Diagnóstico precoz de la inflamación de la vía aérea en el fumador: La asignatura pendiente

Archivos de Bronconeumologia

Volumn 39, Issue 8, 2003, Pages 329-332

  Pacheco Galvan A ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; EARLY DIAGNOSIS; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; RESPIRATORY TRACT INFLAMMATION; SMOKING; SPIROMETRY; TOBACCO;

EID: 0041880657     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13049950     Document Type: Editorial

References (29)

1. Miravitlles M, Fernández I, Guerrero T, Murio C. Desarrollo y resultados de un programa de cribado de la EPOC en atención primaria. El Proyecto PADOC. Arch Bronconeumol 2000;36:500-5.
2. Murray CJ, López AD. Alternative projection of mortality by cause 1990-2020: global burden of disease study. Lancet 1997;349: 1498-504.
3. Shapiro SD. End-stage chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:339-40.
4. Haahtela T. The importance of inflammation in early asthma. Respiratory Medicine 1987;89:461-2.
5. Rytila P, Metso T, Heikkinen K, Saarelainen P, Helenius IJ, Haahtela T. Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J 2000;16: 824-30.
6. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977;115:195-205.
7. O'Byrne PM, Postma DS. The many faces of airway inflammation Am J Respir Crit Care Med 1994;159:S41-S66.
8. Apostol GC, Jacobs DR, Tsai AW, Crow RS, Williams D, Townsend MC, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40. Am J Respir Crit Care Med 2002;166:166-72.
9. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-upe study of ventilation function in adults with asthma. N Engl J Med 1998;339:1194-200.
10. 1. A longitudinal study in the elderly. Am J Respir Crit Care Med 1995;151:656-62.
11. Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:S17-S20.
12. Lams BEA, Sousa AR, Rees PJ, Lee TH. Subepitelial immunopathology of the airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000;15:512-6.
13. Zhu J, Quiu YS, Majumdar S, Gamble E, Matin D, Turato G, et al. Exacerbations of bronchitis: bronchial eosinophilia and gene expresión for IL-4, IL-5, and eosinophil chemoattactans. Am J Respir Crit Care Med 2001;164:109-16.
14. Lebowitz MD, Postma DS, Burrows B. Adverse efects of eosinophils and smoking on the natural history of newly diagnosed chronic bronchitis. Chest 1995;108:55-61.
15. León Fábregas M, De Diego Damiá A, Perpiñá Tordera M. Utilidad del cuestionario de síntomas respiratorios IAUTLD para el diagnóstico diferencial del asma bronquial y la bronquitis crónica. Arch Bronconeumol 2000;36:441-9.
16. Thiadens HA, Postma DS, De Bock GH, Huysman DA, Van Houwelingen HC, Springer MP. Asthma in adult patients presenting with symptoms of acute bronchitis in general practice. Scand J Prim Health Care 2000;18:188-92.
17. Turner-Warwick M, Openshaw P. Sputum in asthma. Postgrad Med J 1987;63(Suppl 1):79-82.
18. US Department of Health and Human Services, Public Health Service. National Heart Lung and Blood Institute. Expert Panel Report II: guidelines for the diagnosis and management of asthma. Bethesda (Maryland): NIH Publication n.° 97.4051, 1997.
19. Annema JT, Sparrow D, O'Connor GT, Rijcken B, Koeter GH, Postma DS, et al. Chronic respiratory symptoms and airway responsiveness to methacholine are associated with eosinophilia in older men: The Normative Aging Study. Eur Respir J 1995;8:62-9.
20. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hiper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000;356:1313-7.
21. Nagai A, Thurlbeck WM, Cono K. Responsiveness and variability of airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:635-9.
22. Gibson PG, Fugimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax 2000; 57:178-82.
23. Brightling CE, Woltman G, Wardlaw AJ, Pavord ID. The development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. Eur Respir J 1999;14:1228-30.
24. Linden M, Rasmussen JB, Piitulainen E, Tunek A, larson M, Tegner H, et al. Airway inflammatin in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993;148: 1226-32.
25. Chanez P, Vignola AM, O'Shaugnessy T, Enander I, Li D, Jeffery PK, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997;155:1529-34.
26. Pizzichini E, Pizzichini MMM, Gibson P, Parameswaran K, Gleich GJ, Berman L, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998;158:1511-7.
27. Matsui S, Yamashita N, Maruyama M, Araya J, Oda H, Fujita T, et al. Acute eosinophilic pneumonia induced by cigarette smoking: positive lymphocyte stimulation test of a cigarette extract. Nihon-Kokyuki-Gakkai-Zasshi 2000;38:807-11.
28. Barter CE, Campbell AH. Reationship of constitutional factors and cigarette smoking to decrease in one-second expiratory volume. Am Rev Respir Dis 1976;113:305-14.
29. Anthonisen NR, Connett JE, Murria RP. Smoking and lung function of lung health study participants after 11 years. Am J Respir Crit Care Med 2002;166:675-9.